Showing 151-160 of 2922 results for "".
Vagus Nerve Stimulation Reduced Rescue Medication Use and Decreased Family Burden
https://practicalneurology.com/programs/practical-neurology/vagus-nerve-stimulation-reduced-rescue-medication-use-and-decreased-family-burden/39913/James Wheless, MD, University of Tennessee Medical Center, Memphis, TN, reports on data demonstrating that using vagus nerve stimulation in patients with drug-resistant epilepsy can reduce rescue medication use, emergency department visits, and hospitalizations while improving patient and family quaPhysicians with Substance Use Disorder, Part I: Overview and A Personal Journey Through Recovery
https://practicalneurology.com/columns/practice-management/physicians-with-substance-use-disorder-part-1-overview-and-a-personal-journey-through-recovery/30090/Chris Bundy, MD, Executive Medical Director, Washington Physicians Health Program, provides an overview of physician substance use disorder, including prevalence, risk factors, and impediments to recovery as well as details about his own journey with recovery.The Belly and the Brain: Weight Management and Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-belly-and-the-brain-weight-management-and-headache/39225/Jennifer Williams McVige, MD, Director of the DENT Concussion Institute and Attending Neurologist at the DENT Neurologic Institute, Buffalo, NY, discusses the clinical evidence linking weight management with the improvement of headache symptoms and outlines practical strategies—including diet and exThe Use of Intracranial Vessel Wall MRI for the Diagnosis of Vasculitis
https://practicalneurology.com/diseases-diagnoses/stroke/the-use-of-intracranial-vessel-wall-mri-for-the-diagnosis-of-vasculitis/37234/Jae W. Song, MD, MS, Associate Professor of Radiology at the University of Pennsylvania, Philadelphia, PA, discusses the diagnostic value of intracranial vessel wall MRI for vasculitis, as well as when clinicians should order this imaging technique and the challenges that may arise.Redefining the Doctor-Patient Partnership: What a Physician-Patient Can Teach Us About Parkinson Disease Care
https://practicalneurology.com/diseases-diagnoses/movement-disorders/redefining-the-doctor-patient-partnership-what-a-physician-patient-can-teach-us-about-parkinson-disease-care/36532/How can neurologists partner with their patients living with Parkinson disease? Kathleen Blake, MD, MPH, Santa Fe, NM, Vice Chair of the Parkinson's Foundation People with Parkinson’s Advisory Council, discusses Parkinson disease care from her unique perspective as both a patient and former physicia- Are We Missing the Connection Between Headache and Fibromyalgia?https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0805CvrFeature-pdf/31413/Dr. Robert L. Knobler’s August 2005 article in *Practical Neurology* critically examines the diagnosis of fibromyalgia syndrome (FMS) and its broader implications for understanding migraines and chronic pain in clinical practice. Knobler highlights the pervasive disregard and overdiagnosis of FMS, o
Frontal Temporal Dementia: A Disease in Progress
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0109_11-php/30963/Increasing knowledge about FTD has important practical implications for neurologists who must accurately diagnose and manage the condition. By Ronald Devere, MDNext-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/next-generation-cns-drug-delivery-brainshuttle-technology-and-clinical-implications-in-alzheimer-disease/67099/In this episode, Luka Kulic, MD, Vice President and Global Head of Early Clinical Development in Neuroscience and Rare Diseases at Roche, Basel, Switzerland, discusses the investigational Brainshuttle technology, including results from the BrainShuttle AD clinical trials as a treatment for early AlzNMOSD Part 3 - Overview of treatment, including goals, triggers, and considerations for switching therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/nmosd-part-3-overview-of-treatment-including-goals-triggers-and-considerations-for-switching-therapies/30089/In this series, Derrick Robertson, MD, Director of the Multiple Sclerosis Division at the University of Southern Florida discusses multiple aspects of NMOSD. Dr. Robertson is talking with us today on behalf of Horizon Therapeutics which is compensating him for his services and is sponsoring this podPD GENEration and Barriers to Parkinson Diagnosis - Part 1
https://practicalneurology.com/diseases-diagnoses/movement-disorders/pd-generation-and-barriers-to-parkinson-diagnosis-part-1/30095/Chantale Branson, MD, Associate Professor of Neurology at Morehouse School of Medicine, Atlanta, GA, is a researcher working on the pivotal PD GENEration study, which aims to improve treatment options through the identification of clinically relevant genes linked to Parkinson disease. In this episod